TriNet Inspire Insights Presents: Find and Fix 7 Common Pitfalls in Biotech Startups
Get Alerts TNET Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.7%
EPS Growth %: -19.1%
Join SI Premium – FREE
SAN LEANDRO, CA -- (Marketwired) -- 11/02/15 -- TriNet (NYSE: TNET) --
WHO: Dr. Craig Shimasaki, co-founder and president & CEO of Moleculera Labs. Dr. Shimasaki is a scientist, businessperson and serial entrepreneur with over 31 years of biotechnology industry experience.
WHAT: Dr. Shimasaki will discuss the seven most common startup mistakes that biotech leaders make and provide insight on how to recognize and repair these mistakes before time and capital run out.
Don't miss this event designed exclusively for biotech entrepreneurs.
Complimentary refreshments, including wine, beer and appetizers will be provided.
WHEN: Thursday, November 5, 2015 at 6 p.m. ET
WHERE: The Benjamin Hotel 125 East 50th St. New York, NY 10022
REGISTER: Register here
For more information join us on #TriNetInsights
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2914067
CONTACT: Jock Breitwieser TriNet [email protected] 510.875.7250
Source: TriNet
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TriNet Group (TNET) Declares $0.29 Quarterly Dividend; 2.5% Yield
- Lendmark Financial Services Expands its Southeast Presence with New Branches in Casselberry, Fla., Winter Garden, Fla., and Gardendale, Ala.
- Automotive Sustainability Leaders to Gather in Michigan for 2026 SP Innovation Summit
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share